Piper Jaffray Maintains Overweight Rating On Mindray Medical

According to Piper Jaffray, Mindray Medical MR maintains Overweight rating. Piper Jaffray said that it cautions investors against over-interpreting a single month of data due to the monthly fluctuations we have seen in the past. “Mindray has indicated that customs export data has limited correlation, if any, with their ex-China sales, even on a quarterly basis.” Mindray Medical closed yesterday at $26.56.